Back to News
Market Impact: 0.42

TKMS H1 2026 slides: EBIT grows 14% as submarine turnaround offsets cash concerns

EMBJ
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsInfrastructure & DefenseManagement & GovernanceCapital Returns (Dividends / Buybacks)Banking & LiquidityM&A & Restructuring
TKMS H1 2026 slides: EBIT grows 14% as submarine turnaround offsets cash concerns

TKMS reported H1 sales of €1.168B, up 10%, and adjusted EBIT of €60M with margin improving to 5.1%, while the submarine division turned sharply better to a 3.5% EBIT margin and backlog rose 13% to €20.6B. The offset was a negative free cash flow swing to €(72)M from €756M and softer Surface Vessels margins, which likely drove the 6.95% share decline. Management reaffirmed FY2025/26 guidance for 2%-5% revenue growth and >6% adjusted EBIT margin, but investors remain focused on cash conversion and execution.

Analysis

The market is signaling that backlog quality and headline order growth are no longer enough; the near-term equity driver is cash conversion. That matters because TKMS is in a classic industrial transition phase where capacity expansion, project ramp, and milestone timing can make earnings look better while equity value remains hostage to working capital discipline. The stock’s pullback looks less like a verdict on demand and more like a discount on the probability that management can turn a defense supercycle into repeatable free cash flow. The real second-order winner is the domestic and European supply chain tied to submarine systems, electronics, and shipyard tooling, because this is where margin expansion can compound fastest as execution scales. By contrast, surface-ship peers with weaker pricing power and heavier campaign spend are likely to face multiple compression if investors start demanding evidence of cash conversion rather than backlog optics. The implied message is that defense spend is still bullish, but the capital is rotating toward the segments with cleaner conversion, better pre-funding, and lower complexity. The contrarian read is that the selloff may be too blunt if the negative free cash flow is genuinely timing-related and H2 is structurally stronger. If that proves out over the next 1-2 quarters, the setup becomes a re-rating trade on sustained submarine margin normalization plus a stronger order-to-cash cadence, especially once the new facility ramp passes the most cash-intensive phase. The main risk is that the market is right: if milestone receipts normalize lower and SG&A keeps rising to chase campaigns, the mid-term margin target stays intact while equity value lags for multiple quarters.